Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Immunology

TL1A in the inflammatory network in autoimmune diseases

Several lines of evidence both from experimental models and from clinical studies reveal that TNF-like ligand 1A (TL1A) and its interaction with death receptor 3 (DR3) is critically involved in the pathogenesis of rheumatoid arthritis and other autoimmune diseases.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Role of TL1A in propagating inflammatory responses in rheumatoid arthritis.

References

  1. Zhang, J. et al. Role of TL1A in the pathogenesis of rheumatoid arthritis. J. Immunol. 183, 5350–5357 (2009).

    Article  CAS  Google Scholar 

  2. Bull, M. J. et al. The Death Receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis. J. Exp. Med. 205, 2457–2464 (2008).

    Article  CAS  Google Scholar 

  3. Bamias, G. et al. Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis. Clin. Immunol. 129, 249–255 (2008).

    Article  CAS  Google Scholar 

  4. Cassatella, M. A. et al. Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis. J. Immunol. 178, 7325–7333 (2007).

    Article  CAS  Google Scholar 

  5. Migone, T. S. et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16, 479–492 (2002).

    Article  CAS  Google Scholar 

  6. Bamias, G. et al. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J. Immunol. 171, 4868–4874 (2003).

    Article  CAS  Google Scholar 

  7. Meylan, F. et al. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Immunity 29, 79–89 (2008).

    Article  CAS  Google Scholar 

  8. Pappu, B. P. et al. TL1A–DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. J. Exp. Med. 205, 1049–1062 (2008).

    Article  CAS  Google Scholar 

  9. Osawa, K., Takami, N., Shiozawa, K., Hashiramoto, A. & Shiozawa, S. Death receptor 3 (DR3) gene duplication in a chromosome region 1p36.3: gene duplication is more prevalent in rheumatoid arthritis. Genes Immun. 5, 439–443 (2004).

    Article  CAS  Google Scholar 

  10. Hayashi, S. et al. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis. Arthritis Rheum. 56, 1067–1075 (2007).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The author is supported by grants from Institut National de le Santé et de la Recherche Médicale, Université Pierre et Marie Curie and Université Paris Descartes.

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bayry, J. TL1A in the inflammatory network in autoimmune diseases. Nat Rev Rheumatol 6, 67–68 (2010). https://doi.org/10.1038/nrrheum.2009.263

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2009.263

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research